About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Cd1d1tm1Luc
targeted mutation 1, Luc Van Kaer
MGI:2180711
Summary 6 genotypes


Genotype
MGI:3765456
hm1
Allelic
Composition		 Cd1d1tm1Luc/Cd1d1tm1Luc
Genetic
Background		 B6.129S6-Cd1d1tm1Luc
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd1d1tm1Luc mutation (2 available); any Cd1d1 mutation (35 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
decreased regulatory T cell number ( J:122245 )
• unlike in wild-type mice, treatment with alpha-GalCer fails to elicit an expansion of regulatory T cells following induction of experimental autoimmune myasthenia gravis
autoimmune response ( J:122245 )
• unlike in wild-type mice, treatment with alpha-GalCer fails to protect mice from experimental autoimmune myasthenia gravis

hematopoietic system
decreased regulatory T cell number ( J:122245 )
• unlike in wild-type mice, treatment with alpha-GalCer fails to elicit an expansion of regulatory T cells following induction of experimental autoimmune myasthenia gravis




Genotype
MGI:4821477
hm2
Allelic
Composition		 Cd1d1tm1Luc/Cd1d1tm1Luc
Genetic
Background		 C.129S6-Cd1d1tm1Luc
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd1d1tm1Luc mutation (2 available); any Cd1d1 mutation (35 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
homeostasis/metabolism
increased blood urea nitrogen level ( J:121187 )
• BUN is elevated in pristane-inoculated mice
increased urine protein level ( J:121187 )
• proteinuria develops early and is more severe in pristane treated mice

renal/urinary system
increased urine protein level ( J:121187 )
• proteinuria develops early and is more severe in pristane treated mice
kidney inflammation ( J:121187 )
• T cells and macrophages are found in the kidney after pristane treatment
glomerulonephritis ( J:121187 )
• diffuse proliferative glomerulonephritis with fibrous crescents, glomerulosclerosis, tubular atrophy, and interstitial fibrosis in 50% of pristane treated mice
glomerulosclerosis ( J:121187 )
• in 50% of pristane treated mice
glomerular crescent ( J:121187 )
• fibrous crescents in 50% of pristane treated mice
renal interstitial fibrosis ( J:121187 )
• in 50% of pristane treated mice
renal tubule atrophy ( J:121187 )
• in 50% of pristane treated mice

immune system
increased IgG3 level ( J:121187 )
• serum levels of IgG3 isotype are significantly higher in pristane-injected mice compared to similarly treated wild-type
decreased interleukin-4 secretion ( J:121187 )
• T cells from pristane treated mice stimulated with anti-CD3 or Con A secrete less IL4
increased anti-nuclear antigen antibody level ( J:121187 )
• anti-ribosomal P Abs and anti-OJ (isoleucyl tRNA synthetase complex) Abs after pristane treatment
increased anti-double stranded DNA antibody level ( J:121187 )
• increased IgG anti-dsDNA Ab levels after pristane treatment
kidney inflammation ( J:121187 )
• T cells and macrophages are found in the kidney after pristane treatment
glomerulonephritis ( J:121187 )
• diffuse proliferative glomerulonephritis with fibrous crescents, glomerulosclerosis, tubular atrophy, and interstitial fibrosis in 50% of pristane treated mice

hematopoietic system
increased IgG3 level ( J:121187 )
• serum levels of IgG3 isotype are significantly higher in pristane-injected mice compared to similarly treated wild-type




Genotype
MGI:3765900
hm3
Allelic
Composition		 Cd1d1tm1Luc/Cd1d1tm1Luc
Genetic
Background		 involves: 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd1d1tm1Luc mutation (2 available); any Cd1d1 mutation (35 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
arrested T cell differentiation ( J:125679 )
• alpha-GalCer-CD1d-reactive T cells are a blocked in their development before reaching the DPdull stage
decreased NK T cell number ( J:39748 )
• the percentages of natural T (NT) cells in the thymus, peripheral lymph nodes, and liver are reduced compared to in wild-type mice
• the percentage of CD4+ NK1.1 cells is reduced 10- to 20-fold while the number of CD4-CD8- NK1.1 cells is reduced 4- to 5-fold compared to in wild-type mice
• the percentage of NT cells in the peripheral lymphoid organs is reduced 3- to 5-fold while the percentage of CD4+CD8- NT cells is reduced 10-fold and the percentage CD4-CD8- NT cells is reduced 2-fold compared to in wild-type mice
• the percentage of CD4+CD8- NT cells is reduced 8-fold while the percentage of CD4-CD8- NT cells is reduced 2-fold compared to in wild-type mice
decreased interferon-gamma secretion ( J:39748 , J:93915 )
• mice produce 2- to 9-fold less interferon-gamma than wild-type mice in response to anti-CD3 antibody stimulation (J:39748)
• in the liver after concanavalin A injection (J:93915)
decreased interleukin-4 secretion ( J:39748 )
• splenocytes produce 9- to 25-fold less IL-4 than wild-type cells when stimulated with anti-CD3 antibodies
decreased tumor necrosis factor secretion ( J:93915 )
• in the liver after concanavalin A injection
decreased acute inflammation ( J:93915 )
• significantly reduced infiltration of neutrophiles into the liver after concanavalin A injection

hematopoietic system
arrested T cell differentiation ( J:125679 )
• alpha-GalCer-CD1d-reactive T cells are a blocked in their development before reaching the DPdull stage
decreased NK T cell number ( J:39748 )
• the percentages of natural T (NT) cells in the thymus, peripheral lymph nodes, and liver are reduced compared to in wild-type mice
• the percentage of CD4+ NK1.1 cells is reduced 10- to 20-fold while the number of CD4-CD8- NK1.1 cells is reduced 4- to 5-fold compared to in wild-type mice
• the percentage of NT cells in the peripheral lymphoid organs is reduced 3- to 5-fold while the percentage of CD4+CD8- NT cells is reduced 10-fold and the percentage CD4-CD8- NT cells is reduced 2-fold compared to in wild-type mice
• the percentage of CD4+CD8- NT cells is reduced 8-fold while the percentage of CD4-CD8- NT cells is reduced 2-fold compared to in wild-type mice

liver/biliary system
abnormal liver morphology ( J:93915 )
• considerably less liver damage induced by concanavalin A injection than in controls
• as measured by alanine transaminase levels

homeostasis/metabolism
decreased physiological sensitivity to xenobiotic ( J:93915 )
• considerably less liver damage induced by concanavalin A injection than in controls
• as measured by alanine transaminase levels




Genotype
MGI:4834138
cx4
Allelic
Composition		 Cd1d1tm1Luc/Cd1d1tm1Luc
Cx3cr1tm1Litt/Cx3cr1tm1Litt
Genetic
Background		 B6.129-Cd1d1tm1Luc Cx3cr1tm1Litt
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd1d1tm1Luc mutation (2 available); any Cd1d1 mutation (35 available)
Cx3cr1tm1Litt mutation (6 available); any Cx3cr1 mutation (45 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
decreased NK cell number ( J:129712 )
• following induction of experimental autoimmune encephalomyelitis (EAE), mice exhibit a similar reduction in NK1.1/TCRbeta- cells in the central nervous system observed in similarly treated Cx3cr1tm1Litt compared with similarly treated wild-type mice
increased susceptibility to experimental autoimmune encephalomyelitis ( J:129712 )
• mice exhibit the same severity of experimental autoimmune encephalomyelitis as Cx3cr1tm1Litt homozygotes

behavior/neurological
paralysis ( J:129712 )
• following induction of experimental autoimmune encephalomyelitis, mice exhibit nonremitting spastic paralysis

hematopoietic system
decreased NK cell number ( J:129712 )
• following induction of experimental autoimmune encephalomyelitis (EAE), mice exhibit a similar reduction in NK1.1/TCRbeta- cells in the central nervous system observed in similarly treated Cx3cr1tm1Litt compared with similarly treated wild-type mice




Genotype
MGI:4821420
cx5
Allelic
Composition		 Cd1d1tm1Luc/Cd1d1tm1Luc
Ldlrtm1Her/Ldlrtm1Her
Genetic
Background		 B6.129S-Cd1d1tm1Luc Ldlrtm1Her
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd1d1tm1Luc mutation (2 available); any Cd1d1 mutation (35 available)
Ldlrtm1Her mutation (19 available); any Ldlr mutation (81 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
cardiovascular system
increased susceptibility to atherosclerosis ( J:110061 )
• male mice after 4 weeks on the Western diet have lesions of small fatty streaks on the aorta were 40.4% smaller than Ldlrtm1Her
• Oil red O stained serial sections of 4-week-old mice fed a western diet, revealed had 31.7% less lipid staining than Ldlrtm1Her

homeostasis/metabolism
decreased circulating VLDL cholesterol level ( J:110061 )
• slightly lower levels of very low density lipoprotein




Genotype
MGI:6094191
cx6
Allelic
Composition		 Cd1d1tm1Luc/Cd1d1tm1Luc
X/Yaa
Genetic
Background		 BXSB.129S6(B6)-Cd1d1tm1Luc/Dcr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd1d1tm1Luc mutation (2 available); any Cd1d1 mutation (35 available)
Yaa mutation (24 available); any Yaa mutation (27 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
premature death ( J:179430 )
• disruption of Cd1d1 does not alter the Yaa-induced premature death on this BXSB background, which causes a mean survival of 32 weeks of age in males




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/10/2024
MGI 6.24 		The Jackson Laboratory